WCN26-7441 The Effect of Intravenous Aminophylline on Preventing Acute Kidney Injury in Sick Neonates – A Multicentric Double blinded, Randomised, Placebo-controlled Clinical Trial

Read full text Summarise with VIRAT
Authors: Sukanya Govindan, Lakshmi Aparna Devi V. V., Arun Krishnan, Stefano Picca, Vijayakumar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neonatal acute kidney injury (nAKI) poses a significant mortality risk, particularly in lower-income countries where treatment options are limited and expertise in neonatal dialysis is scarce. Aminophylline, a non-selective adenosine receptor antagonist, may attenuate AKI by promoting renal blood flow and natriuresis. Although aminophylline has shown benefit in select neonatal subgroups like asphyxia, its efficacy in other critically ill term neonates at high risk for AKI remains unexplored.

Fields of Study & Subjects

Acute Kidney Injury Research Chronic Kidney Disease and Diabetes Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104016–104016
Publication date
25 March 2026
Language
EN